PPVAX:NASDAQ
American Funds Preservation Portfolio Class A – PPVAX Fund Overview
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|
| 9.54 | 0.01 (+0.10%) | 9.24 - 9.61 | -- |
Market data as of 12:00AM 04/04/25. Quotes are delayed by at least 15 min.
Overview - PPVAX
The investment seeks to provide current income, consistent with preservation of capital.
The fund invests in a mix of American Funds fixed income funds. It will principally invest in funds that seek current income through investments in bonds or in other fixed income instruments. The underlying funds may hold securities issued and guaranteed by the U.S. government, securities issued by federal agencies and instrumentalities and securities backed by mortgages or other assets. The investment adviser anticipates that exposure to mortgage-backed securities and asset-backed securities may help the fund generate current income.
Growth of $10,000 (10 Years)
| Total Return | 1.40% |
|---|
| Yield (Trailing 12 Mo.) | 4.04% |
|---|
| Expense Ratio | 0.66% |
|---|
| Front Load | 2.50% |
|---|
| Deferred Load | None |
|---|
| Minimum Investment | $250.00 |
|---|
| Management Tenure | 13 Years |
|---|
| Fund Inception | 05/18/2012 |
|---|
Trailing Total Returns - PPVAX
as of 03/31/2025
| Timeframe | PPVAX | S&P 500 | Short-Term Bond |
|---|
| 1 Month | 0.46% | -5.63% | 0.24% |
|---|
| 3 Month | 2.06% | -4.27% | 1.68% |
|---|
| Year-to-Date | 2.06% | -4.27% | 1.68% |
|---|
| 1 Year | 5.71% | 8.25% | 5.91% |
|---|
| 3 Year | 2.12% | 9.06% | 3.41% |
|---|
| 5 Year | 1.13% | 18.59% | 2.70% |
|---|
| 10 Year | 1.50% | 12.50% | 2.07% |
|---|
| Since Inception | 1.40% | 10.98% | -- |
|---|
Sector Allocation - PPVAX
as of 03/31/2025
| Basic Materials | | -- |
|---|
| Consumer Cyclical | | -- |
|---|
| Financial Services | | -- |
|---|
| Real Estate | | -- |
|---|
| Consumer Defensive | | -- |
|---|
| Healthcare | | -- |
|---|
| Utilities | | -- |
|---|
| Communication Services | | -- |
|---|
| Energy | | -- |
|---|
| Industrials | | -- |
|---|
| Technology | | -- |
|---|
Asset Allocation - PPVAX
as of 03/31/2025
| By Percent | Short | 0% | Long | Net |
|---|
| Stock | 0.00 | | | 0.00 | 0.00 |
|---|
| Bond | 0.00 | | | 85.00 | 85.00 |
|---|
| Other | 0.00 | | | 0.02 | 0.02 |
|---|
| Foreign Stock | 0.00 | | | 0.00 | 0.00 |
|---|
| Foreign Bond | 0.00 | | | 5.87 | 5.87 |
|---|
| Total | 0.00 | | | 90.89 | 90.89 |
|---|
| Cash | 4.42 | | | 13.53 | 9.11 |
|---|
| Total Net Assets | $1.85B |
|---|
| Total Stock Holdings | 0 |
|---|
| Total Bond Holdings | 0 |
|---|
Bond Credit Quality - PPVAX
as of 03/31/2025
| AAA | | 82.50% |
|---|
| AA | | 4.22% |
|---|
| A | | 7.57% |
|---|
| BBB | | 2.61% |
|---|
| BB | | 0.00% |
|---|
| B | | 0.00% |
|---|
| Below B | | 0.00% |
|---|
| Not Rated | | 3.10% |
|---|
Top Ten Holdings - PPVAX
as of 03/31/2025
| Company | YTD Return | % of Assets |
|---|
| RMMGX | -- | 55.01% |
|---|
| RBOGX | -- | 45.01% |
|---|
Valuation & Growth - PPVAX
as of 03/31/2025
| Valuation | PPVAX | Category Range |
|---|
| Price/Earnings | -- | |
|---|
| Price/Book | -- | |
|---|
| Price/Sales | -- | |
|---|
| Price/Cash Flow | -- | |
|---|
| Dividend Yield | | |
|---|
| LT Earnings | | |
|---|
| Historical Earnings | | |
|---|
| Sales Growth | | |
|---|
| Cash-Flow Growth | | |
|---|
| Book-Value Growth | | |
|---|
